Advertisement
Screener

Oscar Health, Inc. (OSCR) Overview

Oscar Health, Inc. (OSCR) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual 1.10; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual 2.07; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.53; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -0.89; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$10.31$13.20$16.90$21.65$27.72$35.502025-11-062026-11-06$2.04$3.62$6.40$11.33$20.05$35.502021-11-082026-11-06$2.04$3.68$6.62$11.91$21.45$38.612021-03-032026-11-06$2.04$3.68$6.62$11.91$21.45$38.612021-03-032026-11-06$2.04$3.68$6.62$11.91$21.45$38.612021-03-032026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$30.63
Previous close
$29.77
Change
$0.86
Change (%)
2.89%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

OSCR
+107.17%
S&P 500
(m)

1 year

OSCR
+55.62%
S&P 500
(m)

3 years

OSCR
+434.47%
S&P 500
(m)

5 years

OSCR
+69.44%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual 1.10

-0.97-0.170.641.452.2531 Mar 2025: estimate (m); actual 0.9231 Mar 2025(m)30 Jun 2025: estimate (m); actual -0.8930 Jun 2025(m)30 Sept 2025: estimate (m); actual -0.5330 Sept 2025(m)31 Mar 2026: estimate (m); actual 2.0731 Mar 2026(m)30 Jun 2026: estimate (m); actual 1.1030 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)1.10(m)(m)
1 Jan 202631 Mar 2026(m)2.07(m)(m)
1 Jul 202530 Sept 2025(m)-0.53(m)(m)
1 Apr 202530 Jun 2025(m)-0.89(m)(m)
1 Jan 202531 Mar 2025(m)0.92(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -1.69

-3.28-2.39-1.50-0.610.2831 Dec 2021: estimate (m); actual -3.2031 Dec 2021(m)31 Dec 2022: estimate (m); actual -2.8531 Dec 2022(m)31 Dec 2023: estimate (m); actual -1.2231 Dec 2023(m)31 Dec 2024: estimate (m); actual 0.1031 Dec 2024(m)31 Dec 2025: estimate (m); actual -1.6931 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-1.69(m)(m)
1 Jan 202431 Dec 2024(m)0.10(m)(m)
1 Jan 202331 Dec 2023(m)-1.22(m)(m)
1 Jan 202231 Dec 2022(m)-2.85(m)(m)
1 Jan 202131 Dec 2021(m)-3.20(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 6.09M ■ Earnings 361.81M — Profit margin 5936.14%

-476.40M-3934.2%-50.01M1335.8%376.39M6605.7%802.79M11875.7%30 Sept 2025: revenue 8.80M; earnings -137.45M; profit margin -1561.75%30 Sept 202531 Dec 2025: revenue 8.96M*; earnings -352.61M*; profit margin -3933.20%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 5.72M; earnings 679.00M; profit margin 11874.71%31 Mar 202630 Jun 2026: revenue 6.09M; earnings 361.81M; profit margin 5936.14%30 Jun 2026

31 Dec 2025 ■ Revenue 28.59M ■ Earnings -443.15M — Profit margin -1549.86%

-686.82M-1550.9%-409.39M-992.4%-131.96M-433.9%145.47M124.6%31 Dec 2022: revenue 64.93M; earnings -606.27M; profit margin -933.78%31 Dec 202231 Dec 2023: revenue 21.35M; earnings -270.73M; profit margin -1267.87%31 Dec 202331 Dec 2024: revenue 20.58M; earnings 25.43M; profit margin 123.60%31 Dec 202431 Dec 2025: revenue 28.59M; earnings -443.15M; profit margin -1549.86%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$30.63(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$30.63High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning OSCR

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$550.74M
Profit margin
1861.94%
Return on assets · 12 month
6.25%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
5.53M
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-2.93%*
Total return · month
-2.30%*
Total return · quarter
1.09%*
Total return · half year
167.24%*
Total return · year to date
107.17%*
Total return · 1 year
55.62%*
Total return · 3 years
434.47%*
Total return · 5 years
69.44%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$29.58M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

Oscar Health, Inc. Overview

View more →

(m)

(m)

SEC CIK
1568651
Industry (SIC)
6324 Hospital & Medical Service Plans
Country of operation
United States
Business address
75 VARICK STREET, 5TH FLOOR, NEW YORK, New York, 10013, United States
Fiscal year end
1231
Phone
(646) 403-3677